Gene symbol: Trim32

Organism: Rattus norvegicus

Summary: Predicted to enable several functions, including identical protein binding activity; ubiquitin binding activity; and ubiquitin protein ligase activity. Predicted to be involved in several processes, including defense response to other organism; positive regulation of protein metabolic process; and regulation of intracellular signal transduction. Predicted to act upstream of or within several processes, including muscle cell cellular homeostasis; positive regulation of cytokine-mediated signaling pathway; and protein ubiquitination. Predicted to be located in nucleus and striated muscle myosin thick filament. Predicted to be active in cytoplasm. Human ortholog(s) of this gene implicated in Bardet-Biedl syndrome; Bardet-Biedl syndrome 11; autosomal recessive limb-girdle muscular dystrophy type 2H; and muscular dystrophy. Orthologous to human TRIM32 (tripartite motif containing 32). [provided by Alliance of Genome Resources, Apr 2022]

NCBI gene ID: 313264 Ensembl:ENSRNOG00000010303 AllianceGenome:RGD:1305238


GO Annotation


Category Term ID Term description
Process GO:0000209 Protein polyubiquitination
Process GO:0001558 Regulation of cell growth
Process GO:0001817 Regulation of cytokine production
Process GO:0001819 Positive regulation of cytokine production
Process GO:0001894 Tissue homeostasis
Process GO:0001959 Regulation of cytokine-mediated signaling pathway
Process GO:0001961 Positive regulation of cytokine-mediated signaling pathway
Process GO:0002376 Immune system process
Process GO:0006355 Regulation of transcription, DNA-templated
Process GO:0006508 Proteolysis
Process GO:0006511 Ubiquitin-dependent protein catabolic process
Process GO:0006807 Nitrogen compound metabolic process
Process GO:0006950 Response to stress
Process GO:0006952 Defense response
Process GO:0006955 Immune response
Process GO:0006996 Organelle organization
Process GO:0007010 Cytoskeleton organization
Process GO:0007275 Multicellular organism development
Process GO:0007399 Nervous system development
Process GO:0008152 Metabolic process
Process GO:0008285 Negative regulation of cell population proliferation
Process GO:0009056 Catabolic process
Process GO:0009057 Macromolecule catabolic process
Process GO:0009314 Response to radiation
Process GO:0009411 Response to UV
Process GO:0009416 Response to light stimulus
Process GO:0009605 Response to external stimulus
Process GO:0009607 Response to biotic stimulus
Process GO:0009615 Response to virus
Process GO:0009628 Response to abiotic stimulus
Process GO:0009889 Regulation of biosynthetic process
Process GO:0009891 Positive regulation of biosynthetic process
Process GO:0009893 Positive regulation of metabolic process
Process GO:0009894 Regulation of catabolic process
Process GO:0009896 Positive regulation of catabolic process
Process GO:0009966 Regulation of signal transduction
Process GO:0009967 Positive regulation of signal transduction
Process GO:0009968 Negative regulation of signal transduction
Process GO:0009987 Cellular process
Process GO:0010033 Response to organic substance
Process GO:0010468 Regulation of gene expression
Process GO:0010506 Regulation of autophagy
Process GO:0010508 Positive regulation of autophagy
Process GO:0010556 Regulation of macromolecule biosynthetic process
Process GO:0010557 Positive regulation of macromolecule biosynthetic process
Process GO:0010604 Positive regulation of macromolecule metabolic process
Process GO:0010628 Positive regulation of gene expression
Process GO:0010646 Regulation of cell communication
Process GO:0010647 Positive regulation of cell communication
Process GO:0010648 Negative regulation of cell communication
Process GO:0010720 Positive regulation of cell development
Process GO:0010803 Regulation of tumor necrosis factor-mediated signaling pathway
Process GO:0010941 Regulation of cell death
Process GO:0010992 Ubiquitin recycling
Process GO:0010994 Free ubiquitin chain polymerization
Process GO:0016043 Cellular component organization
Process GO:0016567 Protein ubiquitination
Process GO:0019219 Regulation of nucleobase-containing compound metabolic process
Process GO:0019222 Regulation of metabolic process
Process GO:0019538 Protein metabolic process
Process GO:0019725 Cellular homeostasis
Process GO:0019941 Modification-dependent protein catabolic process
Process GO:0022008 Neurogenesis
Process GO:0022607 Cellular component assembly
Process GO:0023051 Regulation of signaling
Process GO:0023056 Positive regulation of signaling
Process GO:0023057 Negative regulation of signaling
Process GO:0030029 Actin filament-based process
Process GO:0030030 Cell projection organization
Process GO:0030036 Actin cytoskeleton organization
Process GO:0030047 Actin modification
Process GO:0030154 Cell differentiation
Process GO:0030162 Regulation of proteolysis
Process GO:0030163 Protein catabolic process
Process GO:0030182 Neuron differentiation
Process GO:0030307 Positive regulation of cell growth
Process GO:0030334 Regulation of cell migration
Process GO:0030335 Positive regulation of cell migration
Process GO:0031175 Neuron projection development
Process GO:0031323 Regulation of cellular metabolic process
Process GO:0031325 Positive regulation of cellular metabolic process
Process GO:0031326 Regulation of cellular biosynthetic process
Process GO:0031328 Positive regulation of cellular biosynthetic process
Process GO:0031329 Regulation of cellular catabolic process
Process GO:0031331 Positive regulation of cellular catabolic process
Process GO:0032446 Protein modification by small protein conjugation
Process GO:0032501 Multicellular organismal process
Process GO:0032502 Developmental process
Process GO:0032642 Regulation of chemokine production
Process GO:0032722 Positive regulation of chemokine production
Process GO:0032897 Negative regulation of viral transcription
Process GO:0034097 Response to cytokine
Process GO:0034612 Response to tumor necrosis factor
Process GO:0036211 Protein modification process
Process GO:0040008 Regulation of growth
Process GO:0040012 Regulation of locomotion
Process GO:0040017 Positive regulation of locomotion
Process GO:0042127 Regulation of cell population proliferation
Process GO:0042176 Regulation of protein catabolic process
Process GO:0042221 Response to chemical
Process GO:0042592 Homeostatic process
Process GO:0042981 Regulation of apoptotic process
Process GO:0043066 Negative regulation of apoptotic process
Process GO:0043067 Regulation of programmed cell death
Process GO:0043069 Negative regulation of programmed cell death
Process GO:0043122 Regulation of I-kappaB kinase/NF-kappaB signaling
Process GO:0043123 Positive regulation of I-kappaB kinase/NF-kappaB signaling
Process GO:0043170 Macromolecule metabolic process
Process GO:0043207 Response to external biotic stimulus
Process GO:0043412 Macromolecule modification
Process GO:0043632 Modification-dependent macromolecule catabolic process
Process GO:0043933 Protein-containing complex organization
Process GO:0044085 Cellular component biogenesis
Process GO:0044093 Positive regulation of molecular function
Process GO:0044237 Cellular metabolic process
Process GO:0044238 Primary metabolic process
Process GO:0044248 Cellular catabolic process
Process GO:0044260 Cellular macromolecule metabolic process
Process GO:0044265 Cellular macromolecule catabolic process
Process GO:0044419 Biological process involved in interspecies interaction between organisms
Process GO:0044790 Suppression of viral release by host
Process GO:0045087 Innate immune response
Process GO:0045444 Fat cell differentiation
Process GO:0045595 Regulation of cell differentiation
Process GO:0045597 Positive regulation of cell differentiation
Process GO:0045664 Regulation of neuron differentiation
Process GO:0045666 Positive regulation of neuron differentiation
Process GO:0045732 Positive regulation of protein catabolic process
Process GO:0045787 Positive regulation of cell cycle
Process GO:0045862 Positive regulation of proteolysis
Process GO:0045893 Positive regulation of transcription, DNA-templated
Process GO:0045927 Positive regulation of growth
Process GO:0045935 Positive regulation of nucleobase-containing compound metabolic process
Process GO:0046716 Muscle cell cellular homeostasis
Process GO:0046782 Regulation of viral transcription
Process GO:0048145 Regulation of fibroblast proliferation
Process GO:0048147 Negative regulation of fibroblast proliferation
Process GO:0048468 Cell development
Process GO:0048518 Positive regulation of biological process
Process GO:0048519 Negative regulation of biological process
Process GO:0048522 Positive regulation of cellular process
Process GO:0048523 Negative regulation of cellular process
Process GO:0048525 Negative regulation of viral process
Process GO:0048583 Regulation of response to stimulus
Process GO:0048584 Positive regulation of response to stimulus
Process GO:0048585 Negative regulation of response to stimulus
Process GO:0048666 Neuron development
Process GO:0048699 Generation of neurons
Process GO:0048731 System development
Process GO:0048856 Anatomical structure development
Process GO:0048869 Cellular developmental process
Process GO:0048871 Multicellular organismal homeostasis
Process GO:0050767 Regulation of neurogenesis
Process GO:0050769 Positive regulation of neurogenesis
Process GO:0050789 Regulation of biological process
Process GO:0050792 Regulation of viral process
Process GO:0050793 Regulation of developmental process
Process GO:0050794 Regulation of cellular process
Process GO:0050896 Response to stimulus
Process GO:0051090 Regulation of DNA-binding transcription factor activity
Process GO:0051091 Positive regulation of DNA-binding transcription factor activity
Process GO:0051092 Positive regulation of NF-kappaB transcription factor activity
Process GO:0051094 Positive regulation of developmental process
Process GO:0051128 Regulation of cellular component organization
Process GO:0051147 Regulation of muscle cell differentiation
Process GO:0051149 Positive regulation of muscle cell differentiation
Process GO:0051153 Regulation of striated muscle cell differentiation
Process GO:0051155 Positive regulation of striated muscle cell differentiation
Process GO:0051171 Regulation of nitrogen compound metabolic process
Process GO:0051173 Positive regulation of nitrogen compound metabolic process
Process GO:0051239 Regulation of multicellular organismal process
Process GO:0051240 Positive regulation of multicellular organismal process
Process GO:0051246 Regulation of protein metabolic process
Process GO:0051247 Positive regulation of protein metabolic process
Process GO:0051252 Regulation of RNA metabolic process
Process GO:0051254 Positive regulation of RNA metabolic process
Process GO:0051258 Protein polymerization
Process GO:0051603 Proteolysis involved in protein catabolic process
Process GO:0051607 Defense response to virus
Process GO:0051707 Response to other organism
Process GO:0051726 Regulation of cell cycle
Process GO:0051960 Regulation of nervous system development
Process GO:0051962 Positive regulation of nervous system development
Process GO:0060249 Anatomical structure homeostasis
Process GO:0060255 Regulation of macromolecule metabolic process
Process GO:0060284 Regulation of cell development
Process GO:0060548 Negative regulation of cell death
Process GO:0060759 Regulation of response to cytokine stimulus
Process GO:0060760 Positive regulation of response to cytokine stimulus
Process GO:0061564 Axon development
Process GO:0065003 Protein-containing complex assembly
Process GO:0065007 Biological regulation
Process GO:0065008 Regulation of biological quality
Process GO:0065009 Regulation of molecular function
Process GO:0070647 Protein modification by small protein conjugation or removal
Process GO:0070936 Protein K48-linked ubiquitination
Process GO:0071704 Organic substance metabolic process
Process GO:0071840 Cellular component organization or biogenesis
Process GO:0080090 Regulation of primary metabolic process
Process GO:0080134 Regulation of response to stress
Process GO:0080135 Regulation of cellular response to stress
Process GO:0098542 Defense response to other organism
Process GO:0120036 Plasma membrane bounded cell projection organization
Process GO:0140546 Defense response to symbiont
Process GO:1901564 Organonitrogen compound metabolic process
Process GO:1901565 Organonitrogen compound catabolic process
Process GO:1901575 Organic substance catabolic process
Process GO:1902229 Regulation of intrinsic apoptotic signaling pathway in response to DNA damage
Process GO:1902230 Negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage
Process GO:1902531 Regulation of intracellular signal transduction
Process GO:1902532 Negative regulation of intracellular signal transduction
Process GO:1902533 Positive regulation of intracellular signal transduction
Process GO:1902680 Positive regulation of RNA biosynthetic process
Process GO:1903265 Positive regulation of tumor necrosis factor-mediated signaling pathway
Process GO:1903506 Regulation of nucleic acid-templated transcription
Process GO:1903508 Positive regulation of nucleic acid-templated transcription
Process GO:2000026 Regulation of multicellular organismal development
Process GO:2000145 Regulation of cell motility
Process GO:2000147 Positive regulation of cell motility
Process GO:2001020 Regulation of response to DNA damage stimulus
Process GO:2001021 Negative regulation of response to DNA damage stimulus
Process GO:2001141 Regulation of RNA biosynthetic process
Process GO:2001233 Regulation of apoptotic signaling pathway
Process GO:2001234 Negative regulation of apoptotic signaling pathway
Process GO:2001242 Regulation of intrinsic apoptotic signaling pathway
Process GO:2001243 Negative regulation of intrinsic apoptotic signaling pathway
Process GO:0007014 Actin ubiquitination
Process GO:1903881 Regulation of interleukin-17-mediated signaling pathway
Process GO:1903883 Positive regulation of interleukin-17-mediated signaling pathway
Process GO:1903884 Regulation of chemokine (C-C motif) ligand 20 production
Process GO:1903886 Positive regulation of chemokine (C-C motif) ligand 20 production
Component GO:0005622 Intracellular anatomical structure
Component GO:0005634 Nucleus
Component GO:0005737 Cytoplasm
Component GO:0005863 Striated muscle myosin thick filament
Component GO:0030016 Myofibril
Component GO:0030017 Sarcomere
Component GO:0032982 Myosin filament
Component GO:0036379 Myofilament
Component GO:0043226 Organelle
Component GO:0043227 Membrane-bounded organelle
Component GO:0043228 Non-membrane-bounded organelle
Component GO:0043229 Intracellular organelle
Component GO:0043231 Intracellular membrane-bounded organelle
Component GO:0043232 Intracellular non-membrane-bounded organelle
Component GO:0043292 Contractile fiber
Component GO:0099080 Supramolecular complex
Component GO:0099081 Supramolecular polymer
Component GO:0099512 Supramolecular fiber
Component GO:0110165 Cellular anatomical entity
Function GO:0003676 Nucleic acid binding
Function GO:0003712 Transcription coregulator activity
Function GO:0003713 Transcription coactivator activity
Function GO:0003723 RNA binding
Function GO:0003824 Catalytic activity
Function GO:0004842 Ubiquitin-protein transferase activity
Function GO:0005488 Binding
Function GO:0005515 Protein binding
Function GO:0008092 Cytoskeletal protein binding
Function GO:0008270 Zinc ion binding
Function GO:0016740 Transferase activity
Function GO:0017022 Myosin binding
Function GO:0019787 Ubiquitin-like protein transferase activity
Function GO:0031369 Translation initiation factor binding
Function GO:0032182 Ubiquitin-like protein binding
Function GO:0042802 Identical protein binding
Function GO:0043130 Ubiquitin binding
Function GO:0043167 Ion binding
Function GO:0043169 Cation binding
Function GO:0043621 Protein self-association
Function GO:0046872 Metal ion binding
Function GO:0046914 Transition metal ion binding
Function GO:0061630 Ubiquitin protein ligase activity
Function GO:0061659 Ubiquitin-like protein ligase activity
Function GO:0097159 Organic cyclic compound binding
Function GO:0140096 Catalytic activity, acting on a protein
Function GO:0140110 Transcription regulator activity
Function GO:1901363 Heterocyclic compound binding

Pathway annotation


Category Term ID Term description
RCTM RNO-1280218 Adaptive Immune System
RCTM RNO-168249 Innate Immune System
RCTM RNO-168256 Immune System
RCTM RNO-1834949 Cytosolic sensors of pathogen-associated DNA
RCTM RNO-3134975 Regulation of innate immune responses to cytosolic DNA
RCTM RNO-983168 Antigen processing: Ubiquitination & Proteasome degradation
RCTM RNO-983169 Class I MHC mediated antigen processing & presentation
KEGG rno04120 Ubiquitin mediated proteolysis

Expression profile of Trim32 in omics data



ID GSE100499
Title Exploring acupuncture mechanism in preconditioning of IRI
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM2685201 MX1 tissue: Myocardium gender: male 10.3068695
GSM2685202 MX2 tissue: Myocardium gender: female 10.399365
GSM2685203 MX3 tissue: Myocardium gender: female 10.344705
GSM2685204 MX4 tissue: Myocardium gender: male 10.544568
GSM2685205 DZ1 tissue: Myocardium gender: male 10.599735
GSM2685206 DZ2 tissue: Myocardium gender: male 10.320211
GSM2685207 DZ3 tissue: Myocardium gender: female 10.480189
GSM2685208 DZ4 tissue: Myocardium gender: female 10.467327
GSM2685209 JJ1 tissue: Myocardium gender: male 9.54448
GSM2685210 JJ2 tissue: Myocardium gender: female 10.223816
GSM2685211 JJ3 tissue: Myocardium gender: female 10.104512
GSM2685212 JJ4 tissue: Myocardium gender: male 10.043642
GSM2685213 NG1 tissue: Myocardium gender: male 10.131713
GSM2685214 NG2 tissue: Myocardium gender: female 10.12407
GSM2685215 NG3 tissue: Myocardium gender: male 10.2056
GSM2685216 NG4 tissue: Myocardium gender: female 10.54899
GSM2685217 YL1 tissue: Myocardium gender: male 9.80365
GSM2685218 YL2 tissue: Myocardium gender: male 10.620399
GSM2685219 YL3 tissue: Myocardium gender: female 9.651433
GSM2685220 YL4 tissue: Myocardium gender: female 10.200892
GSM2685221 QC1 tissue: Myocardium gender: male 10.3815365
GSM2685222 QC2 tissue: Myocardium gender: male 10.287275
GSM2685223 QC3 tissue: Myocardium gender: female 10.103313
GSM2685224 QC4 tissue: Myocardium gender: female 10.277401

ID GSE126106
Title Identification of candidate genes and pathways in dexmedetomidine-induced cardioprotection in the rat heart by bioinformatics analysis
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM3591631 Control1 treatment: administration of saline strain: Wistar Sex: male tissue: heart heart region: left ventricle 99.0
GSM3591632 Control2 treatment: administration of saline strain: Wistar Sex: male tissue: heart heart region: left ventricle 92.0
GSM3591633 Control3 treatment: administration of saline strain: Wistar Sex: male tissue: heart heart region: left ventricle 80.0
GSM3591634 Control4 treatment: administration of saline strain: Wistar Sex: male tissue: heart heart region: left ventricle 76.0
GSM3591635 Control5 treatment: administration of saline strain: Wistar Sex: male tissue: heart heart region: left ventricle 76.0
GSM3591636 DEX1 treatment: administration of dexmedetomidine strain: Wistar Sex: male tissue: heart heart region: left ventricle 89.0
GSM3591637 DEX2 treatment: administration of dexmedetomidine strain: Wistar Sex: male tissue: heart heart region: left ventricle 77.0
GSM3591638 DEX3 treatment: administration of dexmedetomidine strain: Wistar Sex: male tissue: heart heart region: left ventricle 70.0
GSM3591639 DEX4 treatment: administration of dexmedetomidine strain: Wistar Sex: male tissue: heart heart region: left ventricle 56.0
GSM3591640 DEX5 treatment: administration of dexmedetomidine strain: Wistar Sex: male tissue: heart heart region: left ventricle 76.0
GSM3591641 miRNA_Control1 treatment: administration of saline strain: Wistar Sex: male tissue: heart heart region: left ventricle
GSM3591642 miRNA_Control2 treatment: administration of saline strain: Wistar Sex: male tissue: heart heart region: left ventricle
GSM3591643 miRNA_Control3 treatment: administration of saline strain: Wistar Sex: male tissue: heart heart region: left ventricle
GSM3591644 miRNA_Control4 treatment: administration of saline strain: Wistar Sex: male tissue: heart heart region: left ventricle
GSM3591645 miRNA_Control5 treatment: administration of saline strain: Wistar Sex: male tissue: heart heart region: left ventricle
GSM3591646 miRNA_DEX1 treatment: administration of dexmedetomidine strain: Wistar Sex: male tissue: heart heart region: left ventricle
GSM3591647 miRNA_DEX2 treatment: administration of dexmedetomidine strain: Wistar Sex: male tissue: heart heart region: left ventricle
GSM3591648 miRNA_DEX3 treatment: administration of dexmedetomidine strain: Wistar Sex: male tissue: heart heart region: left ventricle
GSM3591649 miRNA_DEX4 treatment: administration of dexmedetomidine strain: Wistar Sex: male tissue: heart heart region: left ventricle
GSM3591650 miRNA_DEX5 treatment: administration of dexmedetomidine strain: Wistar Sex: male tissue: heart heart region: left ventricle

ID GSE136833
Title Effects of lidocaine on the expression of rat spinal cord
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4058984 Control_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 4.345771506
GSM4058985 Control_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 4.391222545
GSM4058986 Control_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 4.192934292
GSM4058987 Lidocaine_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 3.959449036
GSM4058988 Lidocaine_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 4.112334081
GSM4058989 Lidocaine_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 4.092520863

ID GSE138454
Title Impact of inflammation on hepatic subcellular energetics in anesthetized rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4108997 Sample 1 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 183.0
GSM4108998 Sample 2 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 193.0
GSM4108999 Sample 3 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 242.0
GSM4109000 Sample 4 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 221.0
GSM4109001 Sample 5 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 154.0
GSM4109002 Sample 6 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 139.0
GSM4109003 Sample 7 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 119.0
GSM4109004 Sample 8 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 335.0
GSM4109005 Sample9 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 169.0
GSM4109006 Sample10 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 231.0
GSM4109007 Sample11 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 172.0
GSM4109008 Sample12 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 309.0
GSM4109009 Sample13 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 64.0
GSM4109010 Sample14 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 103.0
GSM4109011 Sample 15 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 121.0
GSM4109012 Sample16 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 141.0

ID GSE139220
Title Expression data from sevoflurane anesthesia treated rat
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4134285 Brain_Control_rep1 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 6.385543
GSM4134286 Brain_Control_rep2 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 6.585635
GSM4134287 Brain_Control_rep3 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 6.52855
GSM4134288 Brain_Sevoflurane_rep1 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 6.510646
GSM4134289 Brain_Sevoflurane_rep2 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 6.65339
GSM4134290 Brain_Sevoflurane_rep3 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 6.470575

ID GSE143895
Title GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4276356 dhsc01 strain: Sprague Dawley tissue: DHSC treatment: CCI 30.658
GSM4276357 dhsc03 strain: Sprague Dawley tissue: DHSC treatment: CCI 30.797
GSM4276358 dhsc05 strain: Sprague Dawley tissue: DHSC treatment: CCI 27.945
GSM4276359 dhsc13 strain: Sprague Dawley tissue: DHSC treatment: SHAM 28.683
GSM4276360 dhsc15 strain: Sprague Dawley tissue: DHSC treatment: SHAM 30.451

ID GSE157924
Title Regulation of acupuncture on genes in brain stem
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4780973 Rattus_JSSZ(Sham) tissue: Rattus brainstem of modeling treatment: Sham 11.640568
GSM4780974 Rattus_JXZ(Hand Acu) tissue: Rattus brainstem of modeling treatment: Hand Acu 11.66717742
GSM4780975 Rattus_MXZ(TBI) tissue: Rattus brainstem of modeling treatment: TBI 11.65613518

ID GSE1616
Title Genomics of preconditioning
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM27484 APC_a (anesthetic-preconditioning, 1st replicate) 205.7
GSM27485 APC_b (anesthetic-preconditioning, 2nd replicate) 193.4
GSM27486 APC_c (anesthetic-preconditioning, 3rd replicate) 136.7
GSM27487 APC_d (anesthetic-preconditioning, 4th replicate) 138.9
GSM27488 APC_e (anesthetic-preconditioning, 5th replicate) 167.4
GSM27489 APC_TRI_a (trigger of anesthetic-preconditioning, 1st replicate) 47.3
GSM27490 APC_TRI_b (trigger of anesthetic-preconditioning, 2nd replicate) 172.4
GSM27491 APC_TRI_c (trigger of anesthetic-preconditioning, 3rd replicate) 144.3
GSM27492 APC_TRI_d (trigger of anesthetic-preconditioning, 4th replicate) 329.1
GSM27493 APC_TRI_e (trigger of anesthetic-preconditioning, 5th replicate) 67.9
GSM27494 CTL_a (control, 1st replicate) 270.8
GSM27495 CTL_b (control, 2nd replicate) 193.3
GSM27496 CTL_c (control, 3rd replicate) 221.9
GSM27497 CTL_d (control, 4th replicate) 260.5
GSM27498 CTL_e (control, 5th replicate) 191.6
GSM27499 IPC_a (ischemic preconditioning, 1st replicate) 286.1
GSM27500 IPC_b (ischemic preconditioning, 2nd replicate) 177.0
GSM27501 IPC_c (ischemic preconditioning, 3rd replicate) 175.0
GSM27502 IPC_d (ischemic preconditioning, 4th replicate) 121.9
GSM27503 IPC_e (ischemic preconditioning, 5th replicate) 271.1
GSM27504 IPC_TRI_a (trigger of ischemic preconditioning, 1st replicate) 141.7
GSM27505 IPC_TRI_b (trigger of ischemic preconditioning, 2nd replicate) 119.8
GSM27506 IPC_TRI_c (trigger of ischemic preconditioning, 3rd replicate) 182.9
GSM27507 IPC_TRI_d (trigger of ischemic preconditioning, 4th replicate) 152.8
GSM27508 IPC_TRI_e (trigger of ischemic preconditioning, 5th replicate) 83.6
GSM27509 ISCH_a (ischemia, 1st replicate) 330.8
GSM27510 ISCH_b (ischemia, 2nd replicate) 181.5
GSM27511 ISCH_c (ischemia, 3rd replicate) 248.8
GSM27512 ISCH_d (ischemia, 4th replicate) 148.3
GSM27513 ISCH_e (ischemia, 5th replicate) 245.3

ID GSE1779
Title Effect of Isoflurane and LTM on basolateral amygdala
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM30790 baseline control 01 male, 275-300g 1555.2
GSM30791 baseline control 02 male, 275-300g 1614.4
GSM30792 baseline control 03 male, 275-300g 1659.8
GSM30793 baseline control 04 male, 275-300g 1437.4
GSM30794 baseline control 05 male, 275-300g 1486.5
GSM30795 baseline control 06 male, 275-300g 2065.1
GSM30796 baseline control 07 male, 275-300g 1825.4
GSM30797 baseline control 08 male, 275-300g 1803.2
GSM30798 baseline control 09 male, 275-300g 1500.9
GSM30799 pain 01 1462.7
GSM30800 pain 02 1649.2
GSM30801 pain 03 1507.9
GSM30802 pain 04 1510.1
GSM30803 pain 05 1637.5
GSM30804 FC 01 1323.6
GSM30805 FC 02 1355.2
GSM30806 FC 03 1675.0
GSM30807 FC 04 1368.4
GSM30808 FC 05 1521.2
GSM30809 IFC 01 1506.5
GSM30810 IFC 02 1539.2
GSM30811 IFC 03 1334.1
GSM30812 IFC 04 1546.2
GSM30813 IFC 05 1556.8
GSM99800 isoflurane 01 male, 275-300g 1696.2
GSM99801 isoflurane 02 male, 275-300g 1636.6
GSM99802 isoflurane 03 male, 275-300g 1597.3
GSM99803 isoflurane 04 male, 275-300g 1520.4
GSM99804 isoflurane 05 male, 275-300g 1545.7

ID GSE190472
Title Study on VEGF regulation mechanism of acupuncture improving endometrial receptivity in IVF-ET
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5724271 model 21 Sex: female tissue: Uterine tissue condition: model 108.6159
GSM5724272 model 22 Sex: female tissue: Uterine tissue condition: model 124.7996
GSM5724273 model 23 Sex: female tissue: Uterine tissue condition: model 118.5748
GSM5724274 treatment31 Sex: female tissue: Uterine tissue condition: treatment 99.2825
GSM5724275 treatment32 Sex: female tissue: Uterine tissue condition: treatment 91.2682
GSM5724276 treatment33 Sex: female tissue: Uterine tissue condition: treatment 96.1803
GSM5724277 control 41 Sex: female tissue: Uterine tissue condition: control 99.6314
GSM5724278 control 42 Sex: female tissue: Uterine tissue condition: control 115.5222
GSM5724279 control 43 Sex: female tissue: Uterine tissue condition: control 113.8156

ID GSE192399
Title Gene expression of brain regions activated by sevoflurane and propofol
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5746332 LHb, Sevoflurane, 60mins brain region: the lateral habenula (LHb) treatment: Sevoflurane 10.0232
GSM5746333 LHb, O2, 60mins brain region: the lateral habenula (LHb) treatment: O2 10.4927
GSM5746334 MHb, Sevoflurane, 60mins brain region: the medial habenula (MHb) treatment: Sevoflurane 10.5384
GSM5746335 MHb, O2, 60mins brain region: the medial habenula (MHb) treatment: O2 10.7631
GSM5746336 Sol, Sevoflurane, 60mins brain region: the solitary nucleus (Sol) treatment: Sevoflurane 9.4891
GSM5746337 Sol, O2, 60mins brain region: the solitary nucleus (Sol) treatment: O2 9.8206
GSM5746338 Mve, Sevoflurane, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Sevoflurane 10.0753
GSM5746339 Mve, O2, 60mins brain region: the medial vestibular nucleus (MVe) treatment: O2 9.20702
GSM5746340 LHb, Propofol, 60mins brain region: the lateral habenula (LHb) treatment: Propofol 10.4622
GSM5746341 LHb, Intralipos, 60mins brain region: the lateral habenula (LHb) treatment: Intralipos 10.194
GSM5746342 MHb, Propofol, 60mins brain region: the medial habenula (MHb) treatment: Propofol 10.9882
GSM5746343 MHb, Intralipos, 60mins brain region: the medial habenula (MHb) treatment: Intralipos 10.5491
GSM5746344 Sol, Propofol, 60mins brain region: the solitary nucleus (Sol) treatment: Propofol 10.2922
GSM5746345 Sol, Intralipos, 60mins brain region: the solitary nucleus (Sol) treatment: Intralipos 9.5514
GSM5746346 MVe, Propofol, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Propofol 9.74348
GSM5746347 MVe, Intralipos, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Intralipos 9.95965

ID GSE205202
Title Hepatic responses of mice and rats to equivalent acetaminophen (APAP) insult [rat]
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM6208507 Rat_Baseline_0h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 7.74189
GSM6208508 Rat_Baseline_0h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 7.644677
GSM6208509 Rat_Baseline_0h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 7.567955
GSM6208510 Rat_Baseline_0h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 7.544012
GSM6208511 Rat_Baseline_0h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 7.657497
GSM6208512 Rat_Vehicle_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 8.028151
GSM6208513 Rat_Vehicle_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 7.726787
GSM6208514 Rat_Vehicle_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 7.810169
GSM6208515 Rat_Vehicle_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 8.061739
GSM6208516 Rat_Vehicle_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 8.042346
GSM6208517 Rat_Vehicle_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 7.82817
GSM6208518 Rat_Vehicle_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 7.798497
GSM6208519 Rat_Vehicle_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 7.801143
GSM6208520 Rat_Vehicle_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 7.639046
GSM6208521 Rat_Vehicle_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 7.772992
GSM6208522 Rat_Vehicle_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 7.736606
GSM6208523 Rat_Vehicle_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 7.606296
GSM6208524 Rat_Vehicle_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 7.62776
GSM6208525 Rat_Vehicle_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 7.660154
GSM6208526 Rat_Vehicle_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 7.699759
GSM6208527 Rat_Vehicle_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 7.802157
GSM6208528 Rat_Vehicle_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 7.500547
GSM6208529 Rat_Vehicle_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 7.524833
GSM6208530 Rat_Vehicle_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 7.524389
GSM6208531 Rat_Vehicle_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 7.468954
GSM6208532 Rat_APAP_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 7.945476
GSM6208533 Rat_APAP_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 7.521813
GSM6208534 Rat_APAP_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 7.592002
GSM6208535 Rat_APAP_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 7.454549
GSM6208536 Rat_APAP_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 7.788274
GSM6208537 Rat_APAP_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 8.312555
GSM6208538 Rat_APAP_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 8.327339
GSM6208539 Rat_APAP_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 8.29897
GSM6208540 Rat_APAP_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 8.202477
GSM6208541 Rat_APAP_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 8.152396
GSM6208542 Rat_APAP_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 8.131567
GSM6208543 Rat_APAP_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 8.365538
GSM6208544 Rat_APAP_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 8.129043
GSM6208545 Rat_APAP_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 7.961195
GSM6208546 Rat_APAP_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 7.948724
GSM6208547 Rat_APAP_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 7.792501
GSM6208548 Rat_APAP_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 7.681594
GSM6208549 Rat_APAP_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 7.784514
GSM6208550 Rat_APAP_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 7.912195
GSM6208551 Rat_APAP_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 7.818418

ID GSE232804
Title EGR3 regulates opioid-related nociception and motivation in male rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7383519 ww01_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 961.0
GSM7383520 ww02_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 1062.0
GSM7383521 ww03_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 938.0
GSM7383522 ww05_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 907.0
GSM7383523 ww06_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 953.0
GSM7383524 ww07_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 839.0
GSM7383525 ww08_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 958.0
GSM7383526 ww10_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 911.0
GSM7383527 ww12_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 810.0
GSM7383528 ww13_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 1230.0
GSM7383529 ww14_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 895.0
GSM7383530 ww15_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 987.0
GSM7383531 ww16_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 1001.0
GSM7383532 ww17_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 1170.0
GSM7383533 ww18_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 1138.0
GSM7383534 ww20_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 685.0
GSM7383535 ww21_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 976.0
GSM7383536 ww22_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 940.0
GSM7383537 ww23_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 740.0
GSM7383538 ww24_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 757.0
GSM7383539 ww26_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 883.0
GSM7383540 ww27_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 1354.0
GSM7383541 ww28_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 1049.0
GSM7383542 ww30_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 985.0
GSM7383543 ww31_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 972.0
GSM7383544 ww32_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 681.0
GSM7383545 ww34_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 1039.0
GSM7383546 ww35_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 1040.0
GSM7383547 ww36_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 1067.0
GSM7383548 ww37_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 1177.0
GSM7383549 ww38_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 1141.0
GSM7383550 www09_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 1233.0
GSM7383551 www19_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 1150.0
GSM7383552 www29_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 1067.0
GSM7383553 www33_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 1198.0
GSM7383554 www39_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 735.0

ID GSE244436
Title Similarity and dissimilarity in alteration of gene expression profile associated with inhalational anesthesia between sevoflurane and desflurane
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7816143 Liver, Control for SevoAnes tissue: liver genotype: wild type treatment: Control for SevoAnes 4.041027
GSM7816144 Liver, Anesthetized with sevoflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with sevoflurane for 6 h 3.895011
GSM7816145 Liver, Control for DesAnes tissue: liver genotype: wild type treatment: Control for DesAnes 4.58098
GSM7816146 Liver, Anesthetized with desflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with desflurane for 6 h 4.796347

ID GSE2982
Title Effect of inhaled anesthetic to cultured cortical neurons
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM61779 Cell Culture Exposure (control1) Cy3 label;Cy5; -0.06885
GSM61796 Cell Culture Exposure (control2) Cy3; Cy5 -0.0656
GSM61797 Cell Culture Exposure (control3) Cy3; Cy5 -0.13
GSM61798 Cell Culture Exposure (1MAC Halo1) Cy3; Cy5 0.16624999999999998
GSM61799 Cell Culture Exposure (1MAC Halo2) Cy3; Cy5 -0.05795
GSM61800 Cell Culture Exposure (1MAC Halo3) Cy3; Cy5 -0.03902
GSM61801 Cell Culture Exposure (3MAC Halo1) Cy3; Cy5 -0.1164
GSM61802 Cell Culture Exposure (3MAC Halo2) Cy3; Cy5 -0.10550000000000001
GSM61803 Cell Culture Exposure (3MAC Halo3) Cy3; Cy5 -0.183
GSM61804 Cell Culture Exposure (3MAC ISO1) Cy3; Cy5 -0.187
GSM61805 Cell Culture Exposure (3MAC ISO2) Cy3; Cy5 -0.2435
GSM61806 Cell Culture Exposure (3MAC ISO3) Cy3; Cy5 -0.18974999999999997

ID GSE359
Title Isoflurane Single Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5120 Isoflurane single exposure control-1 266.2
GSM5121 Isoflurane single exposure control-2 156.2
GSM5122 Isoflurane single exposure control-3 194.5
GSM5124 Isoflurane single exposure 1 hr-1 159.1
GSM5126 Isoflurane single exposure 1 hr-2 398.0
GSM5127 Isoflurane single exposure 2 hr-1 274.9
GSM5130 Isoflurane single exposure 2 hr-2 274.2
GSM5131 Isoflurane single exposure 2 hr-3 280.2

ID GSE48025
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch1)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 6.634509001
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 6.543607507
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 6.292103599
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 6.292442555
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 6.500007329
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 6.155902121
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 5.681927027
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 6.019437561
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 6.114002462
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 6.204904418
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 6.040163946
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 6.319102428
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 6.10375593
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 6.023233185
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 6.610747786
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 6.325804206
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 6.101605199
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 6.0338272
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 6.086577836
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 5.920620633
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 6.288612851
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 6.27964343
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 5.868507414
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 5.921229167

ID GSE58456
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch 2)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 318.3400887
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 194.6377604
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 442.3842694
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 241.5344872
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 287.0905108
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 217.8684238
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 374.242282
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 235.9391738
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 265.6612608
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 327.7224918
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 317.623565
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 366.6120352
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 296.3430481
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 279.2133061

ID GSE58460
Title Rheumatoid Arthritis Rat Model Treated with Acupuncture
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 6.634509001
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 6.543607507
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 6.292103599
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 6.292442555
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 6.500007329
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 6.155902121
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 5.681927027
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 6.019437561
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 6.114002462
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 6.204904418
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 6.040163946
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 6.319102428
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 6.10375593
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 6.023233185
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 6.610747786
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 6.325804206
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 6.101605199
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 6.0338272
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 6.086577836
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 5.920620633
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 6.288612851
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 6.27964343
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 5.868507414
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 5.921229167
GSM1412003 RAT_NORA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412004 RAT_NORA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412005 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412006 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412007 RAT_NORA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412008 RAT_NORA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412009 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412010 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412011 RAT_MTX_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412012 RAT_MTX_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412013 RAT_ANE_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412014 RAT_ANE_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412015 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412016 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412017 RAT_NORA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412018 RAT_NORA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412019 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412020 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412021 RAT_MTX_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412022 RAT_MTX_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412023 RAT_ANE_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412024 RAT_ANE_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412025 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412026 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412027 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412028 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412029 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412030 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412031 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412032 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412033 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412034 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412035 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412036 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therap 318.3400887
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 194.6377604
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 442.3842694
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 241.5344872
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 287.0905108
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 217.8684238
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therap 374.242282
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 235.9391738
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 265.6612608
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 327.7224918
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 317.623565
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 366.6120352
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 296.3430481
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 279.2133061

ID GSE752
Title Halothane/Isoflurane Repetitive Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5082 Control 1 364.1
GSM5084 Control 2 264.7
GSM5085 Control 3 385.8
GSM5086 Control 4 260.5
GSM5087 Control 5 349.6
GSM5090 Control 6 275.5
GSM5105 Control 7 332.3
GSM5106 Control 8 330.3
GSM5107 Control 9 292.2
GSM5108 Halothane 10 exposure-1 388.0
GSM5109 Halothane 10 exposures-2 274.7
GSM5110 Halothane 10 exposures-3 274.8
GSM5111 Halothane 5 exposures-1 349.9
GSM5112 Halothane 5 exposures-2 354.2
GSM5113 Halothane 5 exposures-3 307.2
GSM5114 Isoflurane 10 exposures-1 373.7
GSM5115 Isoflurane 10 exposures-2 327.2
GSM5116 Isoflurane 10 exposures-3 295.6
GSM5117 Isoflurane 5 exposures-1 320.9
GSM5118 Isoflurane 5 exposures-2 297.4
GSM5119 Isoflurane 5 exposures-3 261.3
GSM11379 Control 10 244.3
GSM11380 Control 11 327.5
GSM11381 Control 12 236.4

ID GSE8911
Title Skeletal muscle after fine needle stimulation
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM225891 Skeletal muscle sample from fine needle-stimulated hindlimb Strain: Lewis, Gender: Male, Body Weight: 275g, Tissue: Skeletal muscle sample from fine nnedle-stimulated hindlimb 104.902
GSM225892 Skeletal muscle sample from control hindlimb Strain: Lewis, Gender: Male, Body weight: 275g, Tissue: skeletal muscle sample from non fine needle-stimulated hindlimb 87.9061